The World of Health & Medicine News

Robert F. Kennedy Jr calls WHO ‘moribund’, urges others to quit

Robert F. Kennedy Jr calls WHO ‘moribund’, urges others to quit

– U.S. Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the World Health Organization as bloated and “moribund” in a video shown to global health officials meeting on Tuesday for the body’s annual assembly in Geneva.

The U.N. agency’s top donor, the United States, announced it would withdraw from the WHO on the first day of Donald Trump’s presidency, leaving the organisation with a massive budget shortfall that it is seeking to address through reforms at this week’s assembly.

“I urge the world’s health ministers and the WHO to take our withdrawal from the organisation as a wake-up call,” he said in a video recorded on Fox News and then streamed to the assembly.

“We’ve already been in contact with like-minded countries and we encourage others to consider joining us,” he said.

His speech did not prompt any immediate response from the assembly. Diplomats and ministers mostly watched the address in silence.

Trump has accused the WHO of mishandling COVID and of being too close to China – allegations it denies.

Kennedy is an environmental lawyer who has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevented millions of deaths for decades, and clashed with U.S. lawmakers last week in a hearing disrupted by protesters.

In his comments to the WHO, Kennedy called it “mired in bureaucratic bloat, entrenched paradigms, conflicts of interest and international power politics.”

“We don’t have to suffer the limits of a moribund WHO – let’s create new institutions or revisit existing institutions that are lean, efficient, transparent and accountable,” he said.

Kennedy’s comments were broadcast hours after WHO member states adopted an agreement on Tuesday to better prepare for future pandemics.

Kennedy said the accord would “lock in all the dysfunctions of the WHO pandemic response.”

spot_img

Explore more

spot_img

US FDA expands use of GSK’s Blujepa as treatment for gonorrhea

US FDA expands use of GSK's Blujepa as treatment for gonorrhea The U.S. Food and Drug Administration said on Thursday it has expanded the use...

WHO chief still hopes Trump administration will rethink withdrawal

WHO chief still hopes Trump administration will rethink withdrawal The World Health Organization chief said on Thursday that he was still hoping the U.S. administration...

FDA approves first new antibiotics to treat gonorrhea in decades, with...

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance  The U.S. health regulator on Friday approved Innoviva's oral...

US FDA Approves First At-Home Device for Depression

US FDA Approves First At-Home Device for Depression The U.S. Food and ‌Drug ​Administration has approved Flow Neuroscience's ‌at-home brain stimulation device to treat depression,...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of...

FDA approves first gene therapy for rare immune disorder

FDA approves first gene therapy for rare immune disorder The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy...

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS Stopping GLP-1 weight-loss drugs before pregnancy appears to increase the risk of complications and preterm delivery, a new...

US FDA approves first drug under new fast-track review program

US FDA approves first drug under new fast-track review program The U.S. Food and Drug Administration approved on Tuesday the ​first drug under its new...